184 related articles for article (PubMed ID: 23694789)
1. Analysis of PITX3 gene in patients with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration.
Jamrozik Z; Berdynski M; Zekanowski C; Baranczyk-Kuzma A; Sławek J; Kuzma-Kozakiewicz M; Maruszak A; Kwiecinski H
Ann Clin Lab Sci; 2013; 43(2):151-3. PubMed ID: 23694789
[TBL] [Abstract][Full Text] [Related]
2. Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.
Josephs KA
J Neurol; 2015 Mar; 262(3):783-8. PubMed ID: 25701010
[TBL] [Abstract][Full Text] [Related]
3. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
5. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
Stamelou M; Quinn NP; Bhatia KP
Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
[TBL] [Abstract][Full Text] [Related]
6. International medical workshop covering progressive supranuclear palsy, Multiple System Atrophy and cortico basal degeneration.
Mov Disord; 2001 Mar; 16(2):382-95. PubMed ID: 11295807
[No Abstract] [Full Text] [Related]
7. Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration.
Divatia R; Khan F; Kishore A
Neurol India; 2007; 55(1):75-7. PubMed ID: 17272907
[TBL] [Abstract][Full Text] [Related]
8. Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.
Schottlaender LV; Polke JM; Ling H; MacDoanld ND; Tucci A; Nanji T; Pittman A; de Silva R; Holton JL; Revesz T; Sweeney MG; Singleton AB; Lees AJ; Bhatia KP; Houlden H
Neurobiol Aging; 2015 Feb; 36(2):1221.e1-6. PubMed ID: 25308964
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
10. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
11. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
12. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
13. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
14. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Josephs KA; Duffy JR
Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
[TBL] [Abstract][Full Text] [Related]
15. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
[TBL] [Abstract][Full Text] [Related]
16. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
[TBL] [Abstract][Full Text] [Related]
17. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
Wakabayashi K; Takahashi H
Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
[TBL] [Abstract][Full Text] [Related]
18. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
19. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Kertesz A; McMonagle P
J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
[TBL] [Abstract][Full Text] [Related]
20. Voxel-based morphometry in autopsy proven PSP and CBD.
Josephs KA; Whitwell JL; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Jack CR
Neurobiol Aging; 2008 Feb; 29(2):280-9. PubMed ID: 17097770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
